News

Chromosome deletion linked to PsA risk


 

References

A deletion between the ADAMTS9 and MAGI1 genes was associated with psoriatic arthritis and is unrelated to purely cutaneous psoriasis, according to Dr. Antonio Juliá of Vall d’Hebron Research Institute, Barcelona, and his associates.

Of 165 common copy number variants found in both the psoriatic arthritis (PsA) group and control group, only the ADAMTS9-MAGI1 deletion showed a significant association, with an odds ratio of 1.94. A deletion between the HLA-C and HLA-B genes was initially significant, but the association disappeared after correcting for alleles located at those genes already associated with PsA.

The ADAMTS9-MAGI1 deletion occurred significantly less often in patients with cutaneous psoriasis (PsC) than in PsA patients, and there was no significant difference in deletion frequency between the control group and the PsC group.

“It is possible, however, that once the specific biological mechanisms influenced by this genetic variation are identified, more targeted analysis will reveal association to other PsA phenotypes,” the investigators noted.

Find the full study in Annals of the Rheumatic Diseases (doi:10.1136/annrheumdis-2014-207190)

lfranki@frontlinemedcom.com

Recommended Reading

Apremilast meets psoriasis endpoints at week 32
MDedge Dermatology
Psoriatic arthritis associated with heavy drinking
MDedge Dermatology
New psoriatic arthritis screening tool passes initial validation
MDedge Dermatology
Late-onset psoriasis genetics identified
MDedge Dermatology
Older psoriasis patients experience more adverse events
MDedge Dermatology
New tool aims to improve monitoring of psoriatic arthritis
MDedge Dermatology
Systemic psoriasis treatment may resolve subclinical enthesitis
MDedge Dermatology
New teaching tool could help doctors screen for PsA
MDedge Dermatology
New psoriatic arthritis risk locus unrelated to psoriasis found
MDedge Dermatology
BSR: Multiple benefits seen with intensive psoriatic arthritis therapy
MDedge Dermatology